Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Inventory: 2024

Historic Inventory for ARS Pharmaceuticals (SPRY) over the last 1 years, with Dec 2024 value amounting to $5.2 million.

  • ARS Pharmaceuticals' Inventory rose 988.39% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 988.39%. This contributed to the annual value of $5.2 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, ARS Pharmaceuticals' Inventory is $5.2 million.
  • ARS Pharmaceuticals' Inventory's 5-year high stood at $5.2 million during FY2024, with a 5-year trough of $5.2 million in FY2024.
  • Its 1-year average for Inventory is $5.2 million, with a median of $5.2 million in 2024.